Encoll Corporation

Latest News

Enhancing Life Through Collagen

Helicoll® is a bioengineered high purity Type-I collagen (>97% pure) forming an acellular skin substitute construct that is highly bioactive, cell conducive, and supportive towards enhancing tissue generation for wound management. Helicoll® is an acellular dermal replacement product and is within the definition of a bioengineered skin substitute. It provides a framework that promotes the regeneration of blood vessels and supports biologic cell migration due to the resorbable properties of Helicoll®. Treatment course typically involves 1 to 4 applications.

About Us

Encoll Corporation

EnColl Corporation, established in 1994, is a California corporation that develops, manufactures and markets Type-I collagen-based products. EnColl uses its patented technology for the preparation of high purity and charge modified collagen (U.S. Patents 5,814,328 (1998); 6,127,143 (2000) & 6,548,077(2003).

The company’s technologies and manufacturing system yields a series of high quality products required for various medical fields such as general and plastic surgery (healing of wounds, burns and dermal ulcers/sores), orthopedic surgery (bone regeneration, spinal fusion), oral surgery (periodontal and dental products), and neurological injuries (brain/nerve regeneration), drug delivery, biopharmaceutical research, and cosmetic & dietary applications.

Why Helicoll®?

News & Events


Helicoll® as a tissue regenerative matrix intervention in NPWT

Why Helicoll® works best for DFU?

How Helicoll® is different from other products?

Helicoll® Showcase Booklet


Scroll to Top